The 2014 Q2 earnings season has been impressive for the Medical sector with 16.1% year-over-year earnings growth on 12.5% increase in revenues. Also, among the 94% sector participants reported so far,...
Johnson & Johnson (NYSE:JNJ), which is one of my favorite long-term stocks for income and dividend-reinvesting investors, just dropped below the $100.00-per-share level and is becoming more attractive...
Per Thomson Reuters, the “forward 4-quarter” estimate for the S&P 500 this past week was $127.07, exactly the same as the past week. The P/E on the forward estimate remained at ...
Add a Comment